Status:
COMPLETED
As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR
Lead Sponsor:
Ege University
Conditions:
Septic Shock
Sepsis, Severe
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The sepsis and septic shock remain major causes of child morbidity and mortality, despite the use of modern antibiotics and resuscitation therapies. Recent interest has focused on biomarkers for early...
Eligibility Criteria
Inclusion
- \<18 years
- Admitted to emergency department with sepsis
Exclusion
- \>18 years
- Diagnosed non-sepsis
Key Trial Info
Start Date :
March 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04459572
Start Date
March 27 2019
End Date
June 25 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University School of Medicine
Izmir, Turkey (Türkiye), 35100